Use of fentanyl vs dexmedetomide as adjuvant to 0.5% Bupivacaine hyperbaric in spinal anaesthesia for total hip replacement surgeries.

Comperative study of dexmedetomidine and fentanyl as an adjuvant to 0.5% Bupivacaine in spinal anesthesia in patient under going for total hip replacement surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058679

Enrollment

Registered

2023-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: Using dexmedetomidine as an adjuvant to o.5% Bupivacaine heavy for spinal anaesthesia in total hip replacement surgeries for 3 hours Control Intervention1: FENTANYL: Ad

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age > 18 years 2 ASA grade1 and 2 3 Scheduled for elective total Hip replacement surgeries under subarachnoid block.

Exclusion criteria

Exclusion criteria: 1Lack of patient’s consent. 2 Age 3 ASA grade 3 and more. 4 Patients with local skin site infections. 5 Patients with hypersensitivity to any of the drugs used. - Pregnant and lactating mothers. - History of serious pulmonary disease, ischemic heart disease, renal/hepatic dysfunction, coronary artery, or cervical spine disease and patients with abnormal coagulation profile.

Design outcomes

Primary

Measure	Time frame
Post operative relief in painTimepoint: 5 hrs	—

Secondary

Measure	Time frame
Heart rate changesTimepoint: 5 hours	—

Countries

India

Contacts

Public ContactVED JAIN

peoples college of medical sciences and research center

jainabhilekh@rediffmail.com9827606268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026